<DOC>
	<DOCNO>NCT02584270</DOCNO>
	<brief_summary>This study fill scientific gap current knowledge provide data evaluation palatal augmentation prosthesis therapeutic modality robust scientific randomize prospective clinical trial . Positive outcome study potential dramatically alter common morbidity oral cancer therapy , namely speech swallow function population patient T1/T2 tumor tongue currently routinely recommended palatal augmentation prosthesis .</brief_summary>
	<brief_title>Prosthesis Guided Speech Rehabilitation T1/T2 Cancers Tongue</brief_title>
	<detailed_description />
	<mesh_term>Mouth Neoplasms</mesh_term>
	<mesh_term>Tongue Neoplasms</mesh_term>
	<criteria>Patients new diagnosis T1/T2 tongue cancer Patients recurrent disease Patients history prior head neck radiation therapy Patients lack adequate maxillary dentition support palatal augmentation prosthesis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>palatal drop prosthesis</keyword>
</DOC>